Paclitaxel

CAS 33069-62-4 29 API suppliersSmall Molecule

Overview

Paclitaxel is a chemotherapy drug used to treat various types of cancer, including ovarian, breast, and non-small cell lung cancer. It works by interfering with the normal function of microtubules during cell division.

API suppliers (29)

Suppliers of Paclitaxel evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India5Taiwan1China1South Korea1France1Netherlands1Italy1

Country recorded for 11 of 29 suppliers.

7 of 29 hold a GMP certificate on record in the EU or UK registers

Showing 25 of 29 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (16 approved US products), the latest listed US patent on Paclitaxel expires 12 Jul 2034. Generic API sourcing typically opens up once these lapse.

Therapeutic areas

OncologyBreast CancerOvarian Cancer
Verified Supplier Partner

Do you supply Paclitaxel? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.